SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-021580
Filing Date
2023-04-28
Accepted
2023-04-28 16:20:04
Documents
22

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20008281x1_def14a.htm   iXBRL DEF 14A 2466093
6 logo_nektar.jpg GRAPHIC 14135
7 ny20008281x1-pc_1.jpg GRAPHIC 647159
8 ny20008281x1-pc_2.jpg GRAPHIC 604818
9 ny20008281x1_graphic01.jpg GRAPHIC 167543
10 ny20008281x1_graphic02.jpg GRAPHIC 167541
11 ny20008281x1_graphic03.jpg GRAPHIC 160991
12 ny20008281x1_graphic04.jpg GRAPHIC 162450
13 ny20008281x1_graphic05.jpg GRAPHIC 146175
  Complete submission text file 0001140361-23-021580.txt   8703467

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nktr-20230608.xsd EX-101.SCH 5581
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20230608_def.xml EX-101.DEF 6665
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20230608_lab.xml EX-101.LAB 20403
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20230608_pre.xml EX-101.PRE 25449
16 EXTRACTED XBRL INSTANCE DOCUMENT ny20008281x1_def14a_htm.xml XML 319231
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 23866611
SIC: 2834 Pharmaceutical Preparations